IL156073A0 - Ion-channel polypeptide and gene, its preparation and use - Google Patents

Ion-channel polypeptide and gene, its preparation and use

Info

Publication number
IL156073A0
IL156073A0 IL15607301A IL15607301A IL156073A0 IL 156073 A0 IL156073 A0 IL 156073A0 IL 15607301 A IL15607301 A IL 15607301A IL 15607301 A IL15607301 A IL 15607301A IL 156073 A0 IL156073 A0 IL 156073A0
Authority
IL
Israel
Prior art keywords
gene
ion
preparation
canion
channel polypeptide
Prior art date
Application number
IL15607301A
Other languages
English (en)
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa filed Critical Genset Sa
Publication of IL156073A0 publication Critical patent/IL156073A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Plant Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15607301A 2000-12-05 2001-12-04 Ion-channel polypeptide and gene, its preparation and use IL156073A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25131700P 2000-12-05 2000-12-05
PCT/IB2001/002798 WO2002046404A2 (fr) 2000-12-05 2001-12-04 Gene et proteine de canal ionique dependant du potentiel, associe a la schizophrenie

Publications (1)

Publication Number Publication Date
IL156073A0 true IL156073A0 (en) 2003-12-23

Family

ID=22951418

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15607301A IL156073A0 (en) 2000-12-05 2001-12-04 Ion-channel polypeptide and gene, its preparation and use

Country Status (16)

Country Link
US (2) US20040091497A1 (fr)
EP (1) EP1339840B1 (fr)
JP (1) JP2004525614A (fr)
KR (1) KR20030074643A (fr)
CN (1) CN1777676A (fr)
AT (1) ATE339500T1 (fr)
AU (2) AU3357302A (fr)
BR (1) BR0115937A (fr)
CA (1) CA2430712A1 (fr)
DE (1) DE60123109T2 (fr)
EA (2) EA006367B1 (fr)
ES (1) ES2271092T3 (fr)
IL (1) IL156073A0 (fr)
MX (1) MXPA03005069A (fr)
UA (1) UA79927C2 (fr)
WO (1) WO2002046404A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020042100A1 (en) * 2000-07-03 2002-04-11 Chunhua Yan Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
WO2002101035A1 (fr) * 2001-05-10 2002-12-19 Mochida Pharmaceutical Co., Ltd. Proteine du canal cation dependant du potentiel
US7634363B2 (en) 2005-12-07 2009-12-15 Affymetrix, Inc. Methods for high throughput genotyping
US20080075789A1 (en) * 2006-02-28 2008-03-27 The Regents Of The University Of California Genes differentially expressed in bipolar disorder and/or schizophrenia
FR2906532B1 (fr) * 2006-09-28 2008-12-12 Biomerieux Sa Nouvel oligonucleotide marque
BR112017007084A8 (pt) * 2014-10-13 2023-02-07 Dow Agrosciences Llc Moléculas de ácido nucleico subunidade copi coatomer alfa que confere resistância a pragas de coleóptero e hemípteros
KR102807004B1 (ko) * 2020-01-03 2025-05-14 삼성전자주식회사 기판 적층 구조를 포함하는 전자 장치
CN114982679B (zh) * 2022-07-22 2023-08-01 中国水产科学研究院长江水产研究所 一种黄鳝家系建立及优良家系选育方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008001A (en) * 1993-11-05 1999-12-28 Yeda Research And Development Co. Ltd. Diagnosis of the susceptibility of contracting schizophrenia
WO1999004825A1 (fr) * 1997-07-22 1999-02-04 Millennium Pharmaceuticals, Inc. Procedes et compositions permettant le diagnostic et le traitement de troubles neuropsychiatriques
EP1042468B1 (fr) * 1997-12-03 2006-10-18 Merck & Co., Inc. Compositions a canaux calcium actives a basse tension et procedes correspondants
AU3530299A (en) * 1998-04-30 1999-11-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) A highly conserved polynucleotide sequence linked to a genetic predisposition toschizophrenia, a method of diagnosis, and applications thereof
CA2331154A1 (fr) * 1998-06-16 1999-12-23 Human Genome Sciences, Inc. Polypeptides presentant une sequence distincte comprenant une sous-unite de facteur de croissance insulinomimetique labile en milieu acide
WO2000022122A2 (fr) * 1998-10-13 2000-04-20 Genset Genes, proteines et marqueurs bialleliques lies a une maladie du systeme nerveux central
JP2002539845A (ja) * 1999-03-30 2002-11-26 ジェンセット 精神分裂病関連遺伝子、タンパク質およびバイアレリックマーカー
EP1280902A2 (fr) * 2000-04-29 2003-02-05 Millennium Pharmaceuticals, Inc. 23949 et 32391, nouveaux canaux ioniques humains, et utilisation associee
EP1313854A2 (fr) * 2000-07-07 2003-05-28 Incyte Genomics, Inc. Transporteurs et canneaux d'ion

Also Published As

Publication number Publication date
DE60123109D1 (de) 2006-10-26
EA008252B1 (ru) 2007-04-27
DE60123109T2 (de) 2007-05-16
EP1339840A2 (fr) 2003-09-03
CA2430712A1 (fr) 2002-06-13
EP1339840B1 (fr) 2006-09-13
EA200300642A1 (ru) 2003-12-25
CN1777676A (zh) 2006-05-24
UA79927C2 (en) 2007-08-10
AU3357302A (en) 2002-06-18
MXPA03005069A (es) 2003-09-05
EA006367B1 (ru) 2005-12-29
JP2004525614A (ja) 2004-08-26
KR20030074643A (ko) 2003-09-19
EA200500974A1 (ru) 2006-02-24
ATE339500T1 (de) 2006-10-15
ES2271092T3 (es) 2007-04-16
US20080184381A1 (en) 2008-07-31
WO2002046404A9 (fr) 2002-08-15
BR0115937A (pt) 2003-09-30
WO2002046404A3 (fr) 2002-12-12
AU2002233573B2 (en) 2007-03-01
US20040091497A1 (en) 2004-05-13
WO2002046404A2 (fr) 2002-06-13

Similar Documents

Publication Publication Date Title
EP2284189A3 (fr) Polypeptides de type facteur de croissance des fibroblastes
EP0837131A3 (fr) Composé contenant la protéine liant la fibronectine obtenu à partir de Staphylococcus
MXPA03002413A (es) Moleculas tipo b7 y uso de las mismas.
DK1378571T3 (da) 5' ESTs for sekreterede proteiner udtrykt i forskellige væv
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
WO1999047669A3 (fr) Sequences d'acide nucleique humain tirees de tissus de tumeurs du sein
WO2001070977A3 (fr) Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
WO2001061007A3 (fr) Molecules du facteur 23 de croissance de fibroblastes et procedes d'utilisation correspondants
WO2001068854A3 (fr) Molecules s'apparentant au facteur de croissance des fibroblastes et leurs utilisations
GB0202556D0 (en) Novel Protein
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
NZ531570A (en) DNA sequences for human angiogenesis genes
WO2004108904A3 (fr) Gene porcin de l'hydroxylase d'acide cmp-n-acetylneuraminique
IL156073A0 (en) Ion-channel polypeptide and gene, its preparation and use
WO1999046374A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
IL154298A0 (en) Papap proteins, their preparation and use
WO1999054447A3 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie
WO2000058510A3 (fr) Genes, proteines, et marqueurs bialleliques associes a la schizophrenie
AU2001233957A1 (en) Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (bad) and unipolar depression
WO2005049793A3 (fr) Methodes et compositions destinees a des approches combinatoires pour la therapie genique du cancer
WO1999046375A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
EP0839910A3 (fr) Spo-rel, homologue de relA/spoT des Staphylocoques
WO2002000872A3 (fr) Compositions et methodes pour le traitement ou la detection de pathologies neurodegeneratives
DE69730967D1 (en) Human dnase ii
WO2001036478A3 (fr) Methodes et compositions se rapportant a des polypeptides et a des polynucleotides similaires au facteur bactericide augmentant la permeabilite